Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial
Stock Information for Tempest Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.